Alcon
The Power List 2018
Mike Ball
CEO, Alcon
How does Alcon support leaders – both internal and external?
We recognize that our success depends on the creativity, dedication and performance of our leaders and associates. That’s why we encourage our leaders to foster a performance-oriented culture that supports achievement through collaboration and innovation, and provide resources for them to do so. We also pride ourselves in offering tailored learning opportunities for our customers. We have developed and launched the Alcon Experience Academy, which allows ophthalmologists and their teams to immerse themselves in our products and technologies, providing a hands-on and engaging experience.
What does it take for a company like Alcon to rise to a position of influence within eyecare?
For more than 70 years, we’ve followed the approach laid out by our founders: “We concentrate our efforts on seeing the needs of patients through the eyes of the specialists who are treating them.” We continue to build on that philosophy by driving continued innovation, excellent customer service and true collaboration across ophthalmology. Everything we do is patient-centered, and we have continuously focused on strengthening our pipeline and improving product quality and availability to drive better outcomes. This approach has led us to the leadership position we are in today and will fuel our growth in the future.
How does Alcon plan to continue leading the field – and making a difference to ophthalmologists and patients – in the coming years?
Innovation is the driving force that will carry Alcon – and our industry – forward. That’s why we must continue building on our long-term partnerships with customers and patients to find new opportunities to collaborate, and address unmet needs through ideation and development. This is a very exciting time to be in ophthalmology. The innovations we’re developing today – from advanced IOL and surgical glaucoma technologies to improved refractive outcomes using cloud data-driven surgical procedures – will sweep in a new era of ophthalmology that hasn’t been seen since the widespread adoption of phacoemulsification technology. This is still in the very early stages and I’m proud that Alcon is helping drive this shift in our industry for the ultimate benefit of patients around the world. With more than 70,000 pieces of Alcon surgical equipment installed globally, we have intensified our clinical and technical service support to optimize patient outcomes.
www.alcon.com
Power List 2018
